GlassScriptPhysician profile
Vijay P Pinto
NPI 1811002371
$4,552.89
in general payments reported to CMS, 2019-2025
36 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $469 · 2021: $967 · 2022: $785 · 2023: $451 · 2024: $597 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,059.39 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $463.48 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $233.46 | 2019-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $232.47 | 2019-2023 | |
| Foundation Medicine, INC. | $183.29 | 2021 | |
| Laborie Medical Technologies Corp. | $181.35 | 2025 | Aquarius Lt |
| Allergan, INC. | $171.77 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $168.00 | 2023-2024 | Gemtesa, Orgovyx |
| Coloplast Corp | $147.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $137.92 | 2021-2023 | Lynparza |
| Myriad Genetic Laboratories, INC. | $129.55 | 2021-2025 | Prolaris |
| Janssen Biotech, INC. | $110.23 | 2022-2024 | Erleada |
| Merck Sharp & Dohme LLC | $109.63 | 2021-2022 | |
| Antares Pharma, INC. | $108.92 | 2021-2022 | |
| Blue Earth Diagnostics | $92.38 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $89.91 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $88.22 | 2019-2020 | |
| Myovant Sciences INC. | $84.45 | 2021-2022 | |
| Intuitive Surgical, INC. | $84.17 | 2024 | |
| Pfizer INC. | $73.22 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $71.53 | 2019-2025 | Adstiladrin |
| Convatec INC. | $66.86 | 2019-2021 | |
| Urogen Pharma, INC. | $66.13 | 2021-2025 | |
| Urovant Sciences INC | $60.41 | 2021-2022 | |
| Tolmar, INC. | $48.61 | 2024 | |
| 180 Medical, INC. | $48.27 | 2019-2022 | |
| Accord Healthcare, INC. | $47.52 | 2024 | |
| Medtronic, INC. | $39.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.21 | 2022 | |
| Baxter Healthcare | $27.31 | 2022 | |
| Calyxo, INC. | $21.24 | 2025 | Cvac Aspiration System |
| Amgen INC. | $18.58 | 2020 | |
| Endo USA, INC. | $18.41 | 2024 | Xiaflex |
| Neotract INC. | $15.36 | 2019 | |
| Medtronic USA, INC. | $12.99 | 2019 | |
| Dornier Medtech America, INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Pinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.